T cells that lack the CD45 transmembrane tyrosine phosphatase have a variety of T-cell receptor (TCR) signaling defects that are corrected by reexpression of wild-type CD45 or its intracytoplasmic domains. In this study, a chimeric molecule containing the myristylation sequence of Src and the intracellular portion of CD45, previously shown to restore function in CD45-T cells, was mutagenized to determine if membrane-associated CD45 tyrosine phosphatase activity is required to restore TCR-mediated signaling in CD45-T cells. Abolition of enzymatic activity by substitution of a serine for a critical cysteine in the first catalytic domain resulted in failure of this molecule to restore TCR signaling. Another mutation, in which a single amino acid substitution destroyed the myristylation site, resulted in failure of the chimeric molecule to partition to the plasma membrane. Although expressed at high levels and enzymatically active, this form of intracellular CD45 also failed to restore normal signaling in CD45-T cells. These findings strongly suggest that CD45's function in TCR signaling requires its proximity to membrane-associated tyrosine phosphatase substrates.
T-cell activation via the T-cell antigen receptor (TCR) is accompanied by increases in tyrosine phosphorylation of many proteins. The known substrates for activation-induced tyrosine kinases include 4 and other chains of the TCR (30, 34) , phospholipase C yl (26) , the ZAP-70 tyrosine kinase (6) , the clathrin-binding valosin-containing protein (10, 29) , Shc (31), Vav (4) , and the cytoskeletal-associated protein ezrin (11) . The importance of tyrosine phosphorylation as a primary event in T-cell activation is supported by several observations. First, tyrosine phosphorylation after TCR perturbation precedes other signals (17) . Second, drugs that inhibit tyrosine kinase activation also prevent TCR-induced increases in intracellular Ca2+ concentration ([Ca2+]1) and hydrolysis of phosphatidylinositol bisphosphate (18, 25) . Third, T cells that lack the Lck or Fyn member of the Src family of tyrosine kinases develop abnormally and have aberrant TCR signaling properties (1, 37, 38) .
While much attention has focused on the role of tyrosine kinases in modulating the state of intracellular protein phosphorylation, it has become clear the tyrosine phosphatases play an equally critical role. Of particular interest is CD45, a transmembrane tyrosine phosphatase expressed by the large majority of bone marrow-derived cells. T-cell lines that have lost expression of CD45 have a variety of abnormal characteristics. Untransformed CD45-T-cell lines fail to proliferate in response to antigen (28) . Transformed and spontaneously proliferating T-cell lines that lose CD45 expression no longer manifest increases in phosphatidylinositol hydrolysis or normal rapid increases in [Ca']i when their TCRs are perturbed (22) . An atypical Ca2' response is maintained, however, as ligation of TCRs on CD45-T cells results in delayed, asynchronous Ca2+ oscillations due to periodic release of Ca2+ from intracellular stores (44) . There are also defects in signaling for tyrosine phosphorylation. In some CD45-cell lines (e.g., Jurkat), baseline tyrosine phosphorylation is normal, but the normal enhancement that usually follows TCR perturbation does not occur (21) . In CD45-YAC-1 T cells, there is marked spontaneous tyrosine hyperphosphorylation, but no further increases are induced after TCR cross-linking (44) . The reason for the differences between cell lines is unknown but presumably reflects differences in other biologically active molecules that may vary between them. Mice in which CD45 has been eliminated by homologous recombination also manifest a variety of lymphocyte abnormalities, including a block in maturation of thymocytes from CD4+ CD8+ to CD4+ CD8-and CD4-CD8+ single-positive cells and poor proliferative responses of peripheral T cells to TCR cross-linking (20) . Thus, loss of CD45 has profound consequences for lymphocyte development and signal transduction.
A number of laboratories have recently used chimeric CD45 constructs to investigate structure-function relationships for this molecule. Transmembrane molecules that consist of the enzymatically active intracellular portion of CD45 and the extracellular portion of either major histocompatibility complex class I (15) or the epidermal growth factor receptor (7) have been made. Expression of either chimeric molecule in a CD45-deficient T-cell line restored TCR-mediated signaling to normal. Our laboratory took a different approach, creating a CD45 chimeric molecule that lacks transmembrane and extracellular regions altogether. This molecule, called myr-iCD45, is composed of the short myristylation sequence from the Nterminal region of Src followed by the enzymatically active intracellular portion of CD45. The N-terminal Src sequence was included to target the chimeric molecule to the plasma membrane. Expression of myr-iCD45 in CD45-YAC-1 T cells restored tyrosine phosphorylation levels and TCR-mediated signaling (increases in [Ca2"]i and phosphorylation of ;) to normal (43) . These data indicate that the intracellular portion of CD45 is itself sufficient to support normal TCR function.
These studies raise a number of interesting questions. First, is the phosphatase activity of CD45 required for its ability to allow normal TCR-mediated signaling? Second, is the localization of the intracellular portion of CD45, especially with regard to its association with membranes, important for its biological function? To address these issues, point mutations resulting in single amino acid substitutions were introduced into the myr-iCD45 chimeric molecule, and the phenotype of T cells expressing these mutated molecules was determined.
MATERIALS AND METHODS Cells. N1 cells are CD45-T cells derived from the YAC-1 T-lymphoma cell line (44) . S1 cells were obtained by transfecting CD45-YAC-1 cells with cDNA encoding the chimeric molecule myr-iCD45, which consists of the NH2-terminal 15 amino acids of Src and the entire intracellular portion of CD45 (43) . Cells designated GA2 and CS269 were derived from N1 cells by transfection with cDNAs encoding myr-iCD45 in which a Gly-*Ala substitution was made at amino acid position 2 and a Cys-Ser mutation was made at position 269, respectively.
Antibodies and reagents. The following monoclonal antibodies were used: 145-2C11 (2C11; anti-CD3-c) (24) Site-directed mutagenesis. The XhoI-SacI cDNA fragment of myr-iCD45 was cloned into pBluescript KS+/-(Stratagene, La Jolla, Calif.). Site-directed mutagenesis was performed with the Transformer site-directed mutagenesis kit (Clontech Laboratories, Inc., Palo Alto, Calif.). This method works by simultaneously annealing two oligonucleotide primers to one strand of denatured double-stranded plasmid. One primer introduces the desired mutation (mutation primer); the second mutates a restriction site unique to the plasmid (selection primer). The sequences were (5'-*3') of our primers as follows: Gly-2---Ala mutation, CGA GCC ATG GCG AGT AGC AAG AGC; and Cys-269-->Ser mutation, GTG GTG CAC AGC AGT GCT GGT G. The sequence at the site of mutation and the surrounding area (-170 enzymatically inactive molecule, the equivalent Cys in myriCD45 (residue 269) was changed to a Ser (Fig. 1) .
The second amino acid (Gly) in the N-terminal sequence of Src is cotranslationally modified by the addition of myristic acid (12) . This modification is essential for the intracellular localization of p60vsrc, since substitution of another amino acid for the Gly prevents its myristylation and stable association with the plasma membrane without affecting tyrosine kinase activity (19, 27) . To try to disrupt membrane association of myr-iCD45 without affecting enzymatic activity, a Gly-2-*Ala substitution was made in the N-terminal Src-like portion of the myr-iCD45 molecule (Fig. 1) .
Expression vectors containing the mutated myr-iCD45 genes were transfected into a CD45-YAC-1 cell line. Transfected lines that grew in the presence of G418 were screened for the presence of the chimeric myr-iCD45 by immunoblotting with an anti-NH2-terminal Src antibody. Figure 2 shows the relative expression of the different forms of myr-iCD45 in YAC-1 transfectants. SI cells express wild-type myr-iCD45 (43) . Two cell lines transfected with the construct containing the Cys-269--Ser substitution expressed comparable (CS269.1) or even greater (CS269.2) levels of myr-iCD45 than Si cells (Fig. 2) . Two other cell lines transfected with an expression vector encoding the Gly-2->Ala substitution also expressed amounts of myr-iCD45 greater than (GA2.1) or equivalent to (GA2.2) that of Si cells (Fig. 2) .
Effect of single amino acid substitutions on tyrosine phosphatase activity. To determine how the mutations in myriCD45 affected enzymatic activity, an anti-NH2-terminal Src antibody or a control anti-LFA-1 antibody was used to immunoprecipitate chimeric molecules from the transfected cell lines, and tyrosine phosphatase activity was measured ( 3A). As previously shown (43) , anti-Src specifically precipitated tyrosine phosphatase activity from S1 cells that express myr-iCD45. Anti-Src also precipitated tyrosine phosphatase activity from cells expressing the Gly-2-->Ala mutation in the Src myristylation sequence, the level of activity correlating well with the amount of protein detected by immunoblotting (Fig.  2) . Therefore, substitution of a single amino acid residue at position 2 of the chimeric molecule had no effect on enzymatic function. Furthermore, as with soluble recombinant mutant molecules (16, 39) , the Cys-269-Ser substitution abrogated the enzymatic activity of the intracellular portion of CD45 when it was expressed in eukaryotic cells, no significant enzymatic activity being detectable even after prolonged incubation with substrate (Fig. 3B ).
Cellular localization of myr-iCD45 and myr-iCD45(GA2). The myr-iCD45 construct was initially designed to try to target the hydrophilic intracellular portion of CD45 to the membrane, where wild-type CD45 is located. To determine if this indeed occurred, and if so what were the consequences of disruption of the myristylation site, S1 and GA2.1 cells were ruptured and the membrane and cytosolic compartments were separated. Each fraction was subjected to immunoprecipitation and then immunoblotting with an anti-NH2-terminal Src antibody (Fig. 4) . As a control, fractions were assayed for the transmembrane TCR t chain. The different cell lines expressed equivalent amounts of (, which, as expected, was detected only in the membrane fraction. As another control, membrane and cytosolic fractions were immunoblotted for tyrosinated at-tubulin, a cytosolic protein (13); tubulin was easily detected in the cytosol but not in membranes (data not shown). For S1 cells, myr-iCD45 was found primarily in the membrane, with very little material detected in the cytosolic fraction. In contrast, the Gly-2--->Ala substitution resulted in a molecule that was detected only in the cytosol. Similar results were obtained with the GA2.2 cell line (data not shown). The anti-Src antibody reproducibly blotted an unidentified 90-to 95-kDa protein present in the cytosol. This activity was nonspecific, in that it was independent of myr-iCD45 expression, and may represent a cross-reaction of the anti-Src antibody with an unidentified cytosolic molecule. In any case, these data demonstrate that the first 15 amino acids of Src do direct the chimeric myr-iCD45 molecule to the membrane, and disruption of the myristylation site results in its localization to the cytoplasm.
Constitutive tyrosine phosphorylation in CD45-cells is not altered by expression of mutant myr-iCD45. For YAC-1 cells, loss of CD45 results in enhanced spontaneous tyrosine phosphorylation of the t chain of the TCR (44), perhaps due to increased activity of Src family member tyrosine kinases such as Lck and Fyn (2) . The consequences of expressing mutated forms of myr-iCD45 on tyrosine phosphorylation were assessed by immunoblotting. Lysates of each cell line were immunoprecipitated with anti-C serum 527, which does not recognize the higher-molecular-weight phosphorylated forms of the molecule (our unpublished observation). Unphosphorylated t migrates with an Mr of 16,000, while for YAC-1 cells, tyrosine-phosphorylated ; migrates with Mrs of 21,000 and 23,000 (44) . All cells expressed equivalent amounts of 16 kDa t (Fig. SB) . When immunoprecipitation was done with anti-c serum 551, which recognizes both phosphorylated and non- phosphorylated 4 (5) , and immunoblotted with antiphosphotyrosine antibodies, it was found that there was much more spontaneously phosphorylated 21-kDa phospho-r and a small amount of 23-kDa phospho-r (seen on longer exposure of the gel) in the CD45-N1 cell line than in the S1 myr-iCD45 transfectant (Fig. 5A) . Consistent with its lack of enzymatic activity, cells expressing myr-iCD45 with the Cys-269-->Ser mutation also had high levels of constitutively phosphorylated t. Despite having levels of anti-Src-precipitable tyrosine phosphatase activity equivalent to that of myr-iCD45, cells expressing myr-iCD45 with the Gly-2-->Ala mutation also had high levels of constitutively phosphorylated t. Identical results were obtained with the GA2.1 and CS269.2 cell lines (data not shown).
An approach that simultaneously detects both phosphorylated and nonphosphorylated t is to immunoprecipitate and then immunoblot with anti-c serum 551. Once again, although all cell lines expressed equivalent amounts of total t chain, the constitutively tyrosine phosphorylated species (21 and 23 kDa) appeared in CD45-cells and cells expressing the Gly-2-->Ala and Cys-269--Ser mutations but not in cells expressing myriCD45 (Fig. 5C ). Therefore, both CD45 tyrosine phosphatase activity and association with the plasma membrane were necessary for the ability of intracellular CD45 to regulate constitutive tyrosine phosphorylation of t. (41) . The reason why so many isoforms are generated is unknown, but the differences in extracellular sequences are presumed to play a role in the interactions of CD45 with ligands expressed on other cells (36) or with other molecules in the plasma membrane of the same cell (8, 42) . Second, CD45 is the major membrane-associated tyrosine phosphatase in T cells (41) . Studies of a number of independently derived CD45-T and B cell lines have demonstrated that it is critical for normal lymphocyte activation.
Recent studies in which chimeric CD45 molecules containing only the intracellular portion of CD45 were transfected into CD45-T-cell lines demonstrated that it alone is sufficient to restore TCR signaling. This result is consistent with, but does not prove, the notion that the tyrosine phosphatase activity of CD45 is essential for normal TCR function. This issue has been addressed in the present study by site-directed mutagenesis of a chimeric construct consisting of a short N-terminal myristylation sequence followed by the intracellular portion of CD45. Although it has been reported that the second catalytic domain of CD45 has intrinsic catalytic activity (40) , substitution of a Ser for Cys-817 (near the COOHterminal end of the first catalytic domain) has been shown to abrogate the enzymatic activity of the intact CD45 molecule (16, 39) . The analogous substitution in myr-iCD45 (Cys-269--Ser) had the same effect, making it possible to examine whether CD45 phosphatase activity is necessary for normal TCR function. The result was clear: none of the CD45-T cells that expressed the inactive enzyme exhibited the large and rapid increase in [Ca2+] i that normally occurs after TCR ligation. Moreover, the TCR 4 chain was spontaneously phosphorylated on tyrosine residues to the same extent as the CD45-cells. Therefore, CD45 tyrosine phosphatase activity is required for normal TCR signaling.
Another issue that could be addressed with the myr-iCD45 chimeric molecule is whether the cellular localization of CD45 contributes to its physiological function. Although CD45 is the predominant tyrosine phosphatase in the plasma membrane, T cells express many other tyrosine phosphatases (33) . In fact, in YAC-1 cells, CD45 accounts for less than half of the total cellular tyrosine phosphatase activity (43) . There are two non-mutually exclusive reasons why these other tyrosine phosphatases might not substitute for CD45 in supporting TCR signaling. First, there could be critical differences in substrate specificity. Second, the intracellular localization of CD45 in the plasma membrane may determine its particular function(s). Like CD45, the chimeric myr-iCD45 is directed to the plasma membrane, in this case by the short myristylation sequence derived from Src. Removal of the Gly at position 2 prevents myristylation and resulted in localization of the chimeric molecule to the cytoplasm. Although chimeric molecules containing the GA2 mutation retained full enzymatic activity, they were unable to restore normal signaling in CD45-T cells. Therefore, CD45 must be membrane anchored for normal function. This presumably reflects the need for CD45 to be near critical substrates in the membrane. CD45 is known to remove phosphate from the regulatory C-terminal residue of Src family member tyrosine kinases, such as Lck and Fyn, which like Src associate with the plasma membrane because of modification with lipid and specific interactions with transmembrane proteins (32) . CD45 also associates with the TCR (42) , and it seems likely that tyrosine-phosphorylated (, and perhaps CD3-E, is also a relevant in vivo substrate. Different CD45 isoforms have been reported to specifically associate with a number of transmembrane molecules involved in T-cell activation (9) , and cross-linking of CD45 to many these molecules alters T-cell activation responses (23) . Such experimental data support the speculation that the biological functions of enzymatically active CD45 may be regulated by specific associations with, or sequestration from, membrane-associated molecules involved in signaling. The possibility that the cellular function of this tyrosine phosphatase is regulated by its cellular localization and/or associations is reminiscent of the Src tyrosine kinase itself, for which mutation of the NH2-terminal glycine prevents its membrane association and ability to transform cells without affected enzymatic activity (3, 19) . The results in this report support the notion that CD45 localization does influence its biological functions and provide direct evidence that contact between it and membrane-associated substrates is essential for its role in signal transduction.
